Proofreading Domain–Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside Analogues Article Swipe

View

Inge C. van Gool , Emily Rayner , Elisabeth M. Osse , Remi A. Nout , Carien L. Creutzberg , Ian Tomlinson , David N. Church , Vincent T.H.B.M. Smit , Niels de Wind , Tjalling Bosse , Mark Drost ·

YOU? · · 2023 · Open Access · · DOI: https://doi.org/10.1158/1078-0432.22470651

Sensitivity to nucleoside analogs cytarabine and fludarabine in Pole S297F-mutant and Pole-wild-type cell lines

Related Topics

Reverse Transcription Polymerase Chain Reaction

Engineering

Electronic Engineering

Mathematical Analysis

Concepts

Proofreading Mutant Nucleoside Chemotherapy Nucleoside analogue Radiation therapy Domain (mathematical analysis) Sensitivity (control systems) Cancer research Chemistry Medicine Biology DNA Internal medicine Genetics Stereochemistry Mathematics Polymerase Gene Engineering Electronic engineering Mathematical analysis

Metadata

Type: preprint
Language: en
Landing Page: https://doi.org/10.1158/1078-0432.22470651
OA Status: gold
Related Works: 10
OpenAlex ID: https://openalex.org/W4362406411

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4362406411

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1158/1078-0432.22470651

Digital Object Identifier
Title: Figure S3 from Adjuvant Treatment for <i>POLE</i> Proofreading Domain–Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside Analogues

Work title
Type: preprint

OpenAlex work type
Language: en

Primary language
Publication year: 2023

Year of publication
Publication date: 2023-03-31

Full publication date if available
Authors: Inge C. van Gool, Emily Rayner, Elisabeth M. Osse, Remi A. Nout, Carien L. Creutzberg, Ian Tomlinson, David N. Church, Vincent T.H.B.M. Smit, Niels de Wind, Tjalling Bosse, Mark Drost

List of authors in order
Landing page: https://doi.org/10.1158/1078-0432.22470651

Publisher landing page
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://doi.org/10.1158/1078-0432.22470651

Direct OA link when available
Concepts: Proofreading, Mutant, Nucleoside, Chemotherapy, Nucleoside analogue, Radiation therapy, Domain (mathematical analysis), Sensitivity (control systems), Cancer research, Chemistry, Medicine, Biology, DNA, Internal medicine, Genetics, Stereochemistry, Mathematics, Polymerase, Gene, Engineering, Electronic engineering, Mathematical analysis

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4362406411
doi	https://doi.org/10.1158/1078-0432.22470651
ids.doi	https://doi.org/10.1158/1078-0432.22470651
ids.openalex	https://openalex.org/W4362406411
fwci	0.0
type	preprint
title	Figure S3 from Adjuvant Treatment for <i>POLE</i> Proofreading Domain–Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside Analogues
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T11287
topics[0].field.id	https://openalex.org/fields/13
topics[0].field.display_name	Biochemistry, Genetics and Molecular Biology
topics[0].score	0.9819999933242798
topics[0].domain.id	https://openalex.org/domains/1
topics[0].domain.display_name	Life Sciences
topics[0].subfield.id	https://openalex.org/subfields/1306
topics[0].subfield.display_name	Cancer Research
topics[0].display_name	Cancer Genomics and Diagnostics
topics[1].id	https://openalex.org/T11395
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.9415000081062317
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2741
topics[1].subfield.display_name	Radiology, Nuclear Medicine and Imaging
topics[1].display_name	Radiopharmaceutical Chemistry and Applications
topics[2].id	https://openalex.org/T12996
topics[2].field.id	https://openalex.org/fields/13
topics[2].field.display_name	Biochemistry, Genetics and Molecular Biology
topics[2].score	0.9366000294685364
topics[2].domain.id	https://openalex.org/domains/1
topics[2].domain.display_name	Life Sciences
topics[2].subfield.id	https://openalex.org/subfields/1305
topics[2].subfield.display_name	Biotechnology
topics[2].display_name	Cancer Research and Treatments
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C170748874
concepts[0].level	4
concepts[0].score	0.8126897811889648
concepts[0].wikidata	https://www.wikidata.org/wiki/Q21117977
concepts[0].display_name	Proofreading
concepts[1].id	https://openalex.org/C143065580
concepts[1].level	3
concepts[1].score	0.6464874148368835
concepts[1].wikidata	https://www.wikidata.org/wiki/Q3285695
concepts[1].display_name	Mutant
concepts[2].id	https://openalex.org/C2776543447
concepts[2].level	2
concepts[2].score	0.5825197696685791
concepts[2].wikidata	https://www.wikidata.org/wiki/Q28734
concepts[2].display_name	Nucleoside
concepts[3].id	https://openalex.org/C2776694085
concepts[3].level	2
concepts[3].score	0.5530616641044617
concepts[3].wikidata	https://www.wikidata.org/wiki/Q974135
concepts[3].display_name	Chemotherapy
concepts[4].id	https://openalex.org/C2777333352
concepts[4].level	3
concepts[4].score	0.5525460839271545
concepts[4].wikidata	https://www.wikidata.org/wiki/Q2689559
concepts[4].display_name	Nucleoside analogue
concepts[5].id	https://openalex.org/C509974204
concepts[5].level	2
concepts[5].score	0.5169388651847839
concepts[5].wikidata	https://www.wikidata.org/wiki/Q180507
concepts[5].display_name	Radiation therapy
concepts[6].id	https://openalex.org/C36503486
concepts[6].level	2
concepts[6].score	0.4970078766345978
concepts[6].wikidata	https://www.wikidata.org/wiki/Q11235244
concepts[6].display_name	Domain (mathematical analysis)
concepts[7].id	https://openalex.org/C21200559
concepts[7].level	2
concepts[7].score	0.46491676568984985
concepts[7].wikidata	https://www.wikidata.org/wiki/Q7451068
concepts[7].display_name	Sensitivity (control systems)
concepts[8].id	https://openalex.org/C502942594
concepts[8].level	1
concepts[8].score	0.424851655960083
concepts[8].wikidata	https://www.wikidata.org/wiki/Q3421914
concepts[8].display_name	Cancer research
concepts[9].id	https://openalex.org/C185592680
concepts[9].level	0
concepts[9].score	0.3513869345188141
concepts[9].wikidata	https://www.wikidata.org/wiki/Q2329
concepts[9].display_name	Chemistry
concepts[10].id	https://openalex.org/C71924100
concepts[10].level	0
concepts[10].score	0.34036874771118164
concepts[10].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[10].display_name	Medicine
concepts[11].id	https://openalex.org/C86803240
concepts[11].level	0
concepts[11].score	0.33434152603149414
concepts[11].wikidata	https://www.wikidata.org/wiki/Q420
concepts[11].display_name	Biology
concepts[12].id	https://openalex.org/C552990157
concepts[12].level	2
concepts[12].score	0.25354933738708496
concepts[12].wikidata	https://www.wikidata.org/wiki/Q7430
concepts[12].display_name	DNA
concepts[13].id	https://openalex.org/C126322002
concepts[13].level	1
concepts[13].score	0.24943527579307556
concepts[13].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[13].display_name	Internal medicine
concepts[14].id	https://openalex.org/C54355233
concepts[14].level	1
concepts[14].score	0.22403505444526672
concepts[14].wikidata	https://www.wikidata.org/wiki/Q7162
concepts[14].display_name	Genetics
concepts[15].id	https://openalex.org/C71240020
concepts[15].level	1
concepts[15].score	0.21619004011154175
concepts[15].wikidata	https://www.wikidata.org/wiki/Q186011
concepts[15].display_name	Stereochemistry
concepts[16].id	https://openalex.org/C33923547
concepts[16].level	0
concepts[16].score	0.14099988341331482
concepts[16].wikidata	https://www.wikidata.org/wiki/Q395
concepts[16].display_name	Mathematics
concepts[17].id	https://openalex.org/C82381507
concepts[17].level	3
concepts[17].score	0.129899799823761
concepts[17].wikidata	https://www.wikidata.org/wiki/Q416878
concepts[17].display_name	Polymerase
concepts[18].id	https://openalex.org/C104317684
concepts[18].level	2
concepts[18].score	0.06754383444786072
concepts[18].wikidata	https://www.wikidata.org/wiki/Q7187
concepts[18].display_name	Gene
concepts[19].id	https://openalex.org/C127413603
concepts[19].level	0
concepts[19].score	0.05857282876968384
concepts[19].wikidata	https://www.wikidata.org/wiki/Q11023
concepts[19].display_name	Engineering
concepts[20].id	https://openalex.org/C24326235
concepts[20].level	1
concepts[20].score	0.0
concepts[20].wikidata	https://www.wikidata.org/wiki/Q126095
concepts[20].display_name	Electronic engineering
concepts[21].id	https://openalex.org/C134306372
concepts[21].level	1
concepts[21].score	0.0
concepts[21].wikidata	https://www.wikidata.org/wiki/Q7754
concepts[21].display_name	Mathematical analysis
keywords[0].id	https://openalex.org/keywords/proofreading
keywords[0].score	0.8126897811889648
keywords[0].display_name	Proofreading
keywords[1].id	https://openalex.org/keywords/mutant
keywords[1].score	0.6464874148368835
keywords[1].display_name	Mutant
keywords[2].id	https://openalex.org/keywords/nucleoside
keywords[2].score	0.5825197696685791
keywords[2].display_name	Nucleoside
keywords[3].id	https://openalex.org/keywords/chemotherapy
keywords[3].score	0.5530616641044617
keywords[3].display_name	Chemotherapy
keywords[4].id	https://openalex.org/keywords/nucleoside-analogue
keywords[4].score	0.5525460839271545
keywords[4].display_name	Nucleoside analogue
keywords[5].id	https://openalex.org/keywords/radiation-therapy
keywords[5].score	0.5169388651847839
keywords[5].display_name	Radiation therapy
keywords[6].id	https://openalex.org/keywords/domain
keywords[6].score	0.4970078766345978
keywords[6].display_name	Domain (mathematical analysis)
keywords[7].id	https://openalex.org/keywords/sensitivity
keywords[7].score	0.46491676568984985
keywords[7].display_name	Sensitivity (control systems)
keywords[8].id	https://openalex.org/keywords/cancer-research
keywords[8].score	0.424851655960083
keywords[8].display_name	Cancer research
keywords[9].id	https://openalex.org/keywords/chemistry
keywords[9].score	0.3513869345188141
keywords[9].display_name	Chemistry
keywords[10].id	https://openalex.org/keywords/medicine
keywords[10].score	0.34036874771118164
keywords[10].display_name	Medicine
keywords[11].id	https://openalex.org/keywords/biology
keywords[11].score	0.33434152603149414
keywords[11].display_name	Biology
keywords[12].id	https://openalex.org/keywords/dna
keywords[12].score	0.25354933738708496
keywords[12].display_name	DNA
keywords[13].id	https://openalex.org/keywords/internal-medicine
keywords[13].score	0.24943527579307556
keywords[13].display_name	Internal medicine
keywords[14].id	https://openalex.org/keywords/genetics
keywords[14].score	0.22403505444526672
keywords[14].display_name	Genetics
keywords[15].id	https://openalex.org/keywords/stereochemistry
keywords[15].score	0.21619004011154175
keywords[15].display_name	Stereochemistry
keywords[16].id	https://openalex.org/keywords/mathematics
keywords[16].score	0.14099988341331482
keywords[16].display_name	Mathematics
keywords[17].id	https://openalex.org/keywords/polymerase
keywords[17].score	0.129899799823761
keywords[17].display_name	Polymerase
keywords[18].id	https://openalex.org/keywords/gene
keywords[18].score	0.06754383444786072
keywords[18].display_name	Gene
keywords[19].id	https://openalex.org/keywords/engineering
keywords[19].score	0.05857282876968384
keywords[19].display_name	Engineering
language	en
locations[0].id	doi:10.1158/1078-0432.22470651
locations[0].is_oa	True
locations[0].source
locations[0].license	cc-by
locations[0].pdf_url
locations[0].version	acceptedVersion
locations[0].raw_type	posted-content
locations[0].license_id	https://openalex.org/licenses/cc-by
locations[0].is_accepted	True
locations[0].is_published	False
locations[0].raw_source_name
locations[0].landing_page_url	https://doi.org/10.1158/1078-0432.22470651
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5083838208
authorships[0].author.orcid	https://orcid.org/0000-0003-0210-3209
authorships[0].author.display_name	Inge C. van Gool
authorships[0].author_position	first
authorships[0].raw_author_name	Inge C. Van Gool
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5066158380
authorships[1].author.orcid	https://orcid.org/0000-0002-0477-9408
authorships[1].author.display_name	Emily Rayner
authorships[1].author_position	middle
authorships[1].raw_author_name	Emily Rayner
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5031287245
authorships[2].author.orcid
authorships[2].author.display_name	Elisabeth M. Osse
authorships[2].author_position	middle
authorships[2].raw_author_name	Elisabeth M. Osse
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5023906981
authorships[3].author.orcid	https://orcid.org/0000-0001-8011-2982
authorships[3].author.display_name	Remi A. Nout
authorships[3].author_position	middle
authorships[3].raw_author_name	Remi A. Nout
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5075073315
authorships[4].author.orcid	https://orcid.org/0000-0002-7008-4321
authorships[4].author.display_name	Carien L. Creutzberg
authorships[4].author_position	middle
authorships[4].raw_author_name	Carien L. Creutzberg
authorships[4].is_corresponding	False
authorships[5].author.id	https://openalex.org/A5040598662
authorships[5].author.orcid	https://orcid.org/0000-0003-3037-1470
authorships[5].author.display_name	Ian Tomlinson
authorships[5].author_position	middle
authorships[5].raw_author_name	Ian P.M. Tomlinson
authorships[5].is_corresponding	False
authorships[6].author.id	https://openalex.org/A5069612368
authorships[6].author.orcid	https://orcid.org/0000-0002-4617-962X
authorships[6].author.display_name	David N. Church
authorships[6].author_position	middle
authorships[6].raw_author_name	David N. Church
authorships[6].is_corresponding	False
authorships[7].author.id	https://openalex.org/A5091322627
authorships[7].author.orcid	https://orcid.org/0000-0003-3730-5652
authorships[7].author.display_name	Vincent T.H.B.M. Smit
authorships[7].author_position	middle
authorships[7].raw_author_name	Vincent T.H.B.M. Smit
authorships[7].is_corresponding	False
authorships[8].author.id	https://openalex.org/A5007581278
authorships[8].author.orcid	https://orcid.org/0000-0002-3143-5061
authorships[8].author.display_name	Niels de Wind
authorships[8].author_position	middle
authorships[8].raw_author_name	Niels de Wind
authorships[8].is_corresponding	False
authorships[9].author.id	https://openalex.org/A5025042206
authorships[9].author.orcid	https://orcid.org/0000-0002-6881-8437
authorships[9].author.display_name	Tjalling Bosse
authorships[9].author_position	middle
authorships[9].raw_author_name	Tjalling Bosse
authorships[9].is_corresponding	False
authorships[10].author.id	https://openalex.org/A5072877422
authorships[10].author.orcid
authorships[10].author.display_name	Mark Drost
authorships[10].author_position	last
authorships[10].raw_author_name	Mark Drost
authorships[10].is_corresponding	False
has_content.pdf	False
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://doi.org/10.1158/1078-0432.22470651
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Figure S3 from Adjuvant Treatment for <i>POLE</i> Proofreading Domain–Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside Analogues
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T11287
primary_topic.field.id	https://openalex.org/fields/13
primary_topic.field.display_name	Biochemistry, Genetics and Molecular Biology
primary_topic.score	0.9819999933242798
primary_topic.domain.id	https://openalex.org/domains/1
primary_topic.domain.display_name	Life Sciences
primary_topic.subfield.id	https://openalex.org/subfields/1306
primary_topic.subfield.display_name	Cancer Research
primary_topic.display_name	Cancer Genomics and Diagnostics
related_works	https://openalex.org/W2015735719, https://openalex.org/W2070851085, https://openalex.org/W1986270813, https://openalex.org/W2048312581, https://openalex.org/W4232769227, https://openalex.org/W2000636526, https://openalex.org/W1989167464, https://openalex.org/W2169347489, https://openalex.org/W2792159052, https://openalex.org/W3032669055
cited_by_count	0
locations_count	1
best_oa_location.id	doi:10.1158/1078-0432.22470651
best_oa_location.is_oa	True
best_oa_location.source
best_oa_location.license	cc-by
best_oa_location.pdf_url
best_oa_location.version	acceptedVersion
best_oa_location.raw_type	posted-content
best_oa_location.license_id	https://openalex.org/licenses/cc-by
best_oa_location.is_accepted	True
best_oa_location.is_published	False
best_oa_location.raw_source_name
best_oa_location.landing_page_url	https://doi.org/10.1158/1078-0432.22470651
primary_location.id	doi:10.1158/1078-0432.22470651
primary_location.is_oa	True
primary_location.source
primary_location.license	cc-by
primary_location.pdf_url
primary_location.version	acceptedVersion
primary_location.raw_type	posted-content
primary_location.license_id	https://openalex.org/licenses/cc-by
primary_location.is_accepted	True
primary_location.is_published	False
primary_location.raw_source_name
primary_location.landing_page_url	https://doi.org/10.1158/1078-0432.22470651
publication_date	2023-03-31
publication_year	2023
referenced_works_count	0
abstract_inverted_index.in	7
abstract_inverted_index.to	1
abstract_inverted_index.and	5, 10
abstract_inverted_index.Pole	8
abstract_inverted_index.cell	12
abstract_inverted_index.analogs	3
abstract_inverted_index.cytarabine	4
abstract_inverted_index.nucleoside	2
abstract_inverted_index.fludarabine	6
abstract_inverted_index.S297F-mutant	9
abstract_inverted_index.Pole-wild-type	11
abstract_inverted_index.lines</p>	13
abstract_inverted_index.<p>Sensitivity	0
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	11
citation_normalized_percentile.value	0.26572772
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False